Good morning, and welcome to the 2026 annual meeting of stockholders of Crinetics Pharmaceuticals. The stockholder meeting will begin now and will be chaired by Crinetics founder and Chief Executive Officer, Dr. Scott Struthers. Dr. Struthers, you may begin.
Good morning. I am Scott Struthers, founder, Chief Executive Officer, and a member of the board of directors of Crinetics Pharmaceuticals. I'm very happy to welcome you to the Crinetics 2026 annual meeting of stockholders. I will serve as chair of the meeting. We are hosting this meeting in a virtual-only format. If you encounter any technical difficulties accessing or participating in the meeting, please call the toll-free number provided in the virtual meeting registration email. Deepak Bhandarkar of PricewaterhouseCoopers LLP, the company's independent registered public accounting firm, is also on the line today and will be available to respond to appropriate questions from stockholders. After the formal meeting has been adjourned, we will provide time for general questions. Only validated stockholders may ask questions in the designated field on the web portal. Of consideration for others, please limit yourself to one question.
Please note that this meeting is being recorded. However, no one attending via the webcast or telephone is permitted to use any audio recording device. The meeting will now officially come to order. We will proceed with the formal business of the meeting as set forth in our proxy statement. Mr. Schilke, will you please report at this time with respect to the mailing of the notice of Internet availability of proxy materials and the stockholder list?
I have at this meeting a complete list of the company's stockholders of record as of April 20th, 2026, the record date for this meeting, which shows that 105,439,535 shares of common stock are entitled to vote at this meeting. I also have an affidavit certifying that on April 29th, 2026, a notice of Internet availability of proxy materials was deposited in the United States mail. These materials were shared with all stockholders of record as of the close of business on April 20th, 2026. If any shareholder would like to request a copy of the list of the company's stockholders of record, they may do so by writing to the corporate secretary at our corporate address listed on our website, www.crinetics.com.
James Alden will act as Inspector of Election at this meeting. Mr. Alden has taken and subscribed the customary oath of office to execute his duties with strict impartiality. We will file this oath with the records of the meeting. His function is to decide upon the qualification of voters, accept their votes, and when balloting on all matters is completed, to tally the final votes. Mr. Schilke, will you please provide the inspector's report at this time with respect to the existence of a quorum?
The inspector has advised me that a quorum is present. We may now carry out the official business of the meeting.
We'll now proceed with the formal business of this meeting. There are three proposals to be considered by the stockholders at this meeting.
It is now shortly after eight o'clock A.M. P.T. on Thursday, June 18th, 2026. The polls are now open for voting on all matters to be presented. The polls will be closed to voting after we go through the matters on which to be voted. You do not need to vote today if you have already sent in your signed proxy or voted via telephone or Internet. Any stockholder who has not yet voted or wishes to change their vote may do so by following the instruction on the meeting page you used to enter this meeting. Each share of common stock is entitled to one vote.
First item of business is the election of three Class two directors to serve until the 2029 annual meeting and their successors are elected. The nominees for Class two directors are Caren Deardorf, Dr. Weston Nichols, and Stephanie S. Okey. The second item of business today is the ratification of the selection of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the independent registered public accounting firm of the company for the fiscal year ending December 31, 2026. The third item of business is to vote upon, on an advisory basis, the compensation of the company's named executive officers as disclosed in the proxy statement.
Now that everyone has had the opportunity to vote, I now declare the polls for the 2026 annual meeting of shareholders closed.
I have been informed by Mr. Schilke that based on the preliminary voting results of proxy votes we have received, each of Caren Deardorf, Dr. Weston Nichols, and Stephanie S. Okey has been elected as a Class two director of the company. The selection of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026, has been ratified. The compensation of the company's named executive officers, as disclosed in the proxy statement, has been approved on an advisory basis. We will report our final voting results on the current report on Form 8-K to be filed with the SEC within four business days after the end of this meeting. This concludes the formal portion of today's meeting. The meeting is now adjourned. I would like to thank each of you once again for attending.
We look forward to updating you on the future on our progress. Now, we would like to open things up for stockholder questions. We will take stockholder questions that are being entered today on the web portal. Please note we will attempt to answer as many questions as time allows, but only questions that are germane to the meeting will be addressed. Seeing as there are no questions, this concludes the question- and- answer portion of the meeting. Thank you for your attendance this morning. We thank you for your continued support of Crinetics and wish you all of the best.
Ladies and gentlemen, that will conclude today's meeting. We do thank you for joining. You may now disconnect your line.